Patent details

EP1730200 Title: Method for quantitatively determining specific constituting heparins or low molecular weight heparins using HPLC

Basic Information

Publication number:
EP1730200
PCT Application Number:
PCT/EP/2005/003720
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057314296
PCT Publication Number:
WO/2005/090409
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Method for quantitatively determining specific constituting heparins or low molecular weight heparins using HPLC
French Title of Invention:
Procédé de détermination quantitative de groupes spécifiques constituant des héparines ou d'héparines a faible poids moleculaire au moyens d'une CLHP
German Title of Invention:
Verfahren zur quantitativen Bestimmung von spezifischen Gruppen von Heparinen oder niedermolekularen Heparinen mittels HPLC
SPC Number:

Dates

Filing date:
22/03/2005
Grant date:
23/04/2014
EP Publication Date:
23/04/2014
PCT Publication Date:
29/09/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/12/2006
EP B1 Publication Date:
23/04/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/03/2015
Expiration date:
22/03/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/03/2005
 
 

Name:
Aventis Pharma S.A.
Address:
20, avenue Raymond Aron, 92160 Antony, France (FR)

Inventor

1

Name:
MOURIER Pierre
Address:
France (FR)

2

Name:
VISKOV Christian
Address:
France (FR)

Priority

Priority Number:
04290790
Priority Date:
24/03/2004
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
C08B 37/00;
Filing date Document type Number of pages